A tell-tail sign of chromatin: histone mutations drive pediatric glioblastoma.
Cancer Cell
Authors | |
Abstract | Recent genomic analyses of pediatric glioblastoma, a poorly understood tumor with dismal outcome, have identified mutations in histone H3 variants that affect critical amino acids in the tail. The findings extend discoveries of chromatin regulator inactivation and gain-of-function mutations by documenting alteration of a modifiable histone residue in human cancer. |
Year of Publication | 2012
|
Journal | Cancer Cell
|
Volume | 21
|
Issue | 3
|
Pages | 329-31
|
Date Published | 2012 Mar 20
|
ISSN | 1878-3686
|
URL | |
DOI | 10.1016/j.ccr.2012.03.001
|
PubMed ID | 22439930
|
Links | |
Grant list | R01 CA057683 / CA / NCI NIH HHS / United States
|